EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+3.61%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$444M
AUM Growth
+$444M
(-27%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-39.3%
Top 10 Holdings %
Top 10 Hldgs %
61.1%
Holding
76
New
8
Increased
11
Reduced
27
Closed
24
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$24.7M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$21.6M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$12M |
| 4 |
OraSure Technologies
OSUR
|
$11.4M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$6.87M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$39.5M |
| 2 |
AstraZeneca
AZN
|
$27.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$27M |
| 4 |
Danaher
DHR
|
$16.5M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$15.7M |
Sector Composition
| 1 | Healthcare | 98.23% |
| 2 | Communication Services | 1.5% |
| 3 | Financials | 0.04% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $47.2M | 10.49% | 607,757 -346,981 | -36% | -$27M |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $44.9M | 9.97% | 10,653,459 +5,867,358 | +123% | +$24.7M |
|
|
3
TG Therapeutics
TGTX
$4.65B
| $27.4M | 6.08% | 1,023,330 -1,477,942 | -59% | -$39.5M |
|
4
Ascendis Pharma
ASND
$11.8B
| $24.8M | 5.52% | 161,004 -59,340 | -27% | -$9.16M |
|
5
United Therapeutics
UTHR
$13.8B
| $24.3M | 5.41% | 240,904 +8,228 | +4% | +$831K |
|
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $21.6M | 4.79% | +2,394,355 | New | +$21.6M |
|
7
Fate Therapeutics
FATE
$120M
| $21.4M | 4.75% | 535,036 +3,778 | +0.7% | +$151K |
|
|
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.9M | 4.65% | 321,581 -126,683 | -28% | -$8.24M |
|
|
DCPH
9
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $20.6M | 4.59% | 402,433 -16,219 | -4% | -$832K |
|
10
The Ensign Group
ENSG
$9.91B
| $18.2M | 4.05% | 318,863 -108,444 | -25% | -$6.19M |
|
|
HSKA
11
DELISTED
Heska Corp
HSKA
| $15.7M | 3.49% | 158,772 -121,484 | -43% | -$12M |
|
|
ZGNX
12
DELISTED
Zogenix, Inc.
ZGNX
| $15.5M | 3.45% | 865,241 -141,842 | -14% | -$2.54M |
|
|
CTLT
13
DELISTED
CATALENT, INC.
CTLT
| $12M | 2.67% | +140,329 | New | +$12M |
|
|
14
OraSure Technologies
OSUR
$242M
| $11.4M | 2.54% | +940,412 | New | +$11.4M |
|
|
15
Amneal Pharmaceuticals
AMRX
$3B
| $10.3M | 2.29% | 2,656,208 +1,769,621 | +200% | +$6.87M |
|
16
Standard BioTools
LAB
$481M
| $9.68M | 2.15% | 1,302,353 +834,430 | +178% | +$6.2M |
|
17
Qiagen
QGEN
$10.1B
| $8.75M | 1.94% | 167,473 +85,007 | +103% | +$4.44M |
|
|
TARO
18
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.78M | 1.73% | 141,889 +36,720 | +35% | +$2.01M |
|
|
19
Danaher
DHR
$147B
| $6.76M | 1.5% | 31,360 -76,497 | -71% | -$16.5M |
|
|
MODN
20
DELISTED
MODEL N, INC.
MODN
| $6.67M | 1.48% | 188,967 -151,797 | -45% | -$5.36M |
|
21
HCA Healthcare
HCA
$94.5B
| $6.53M | 1.45% | 52,400 +22,000 | +72% | +$2.74M |
|
22
Aurinia Pharmaceuticals
AUPH
$1.58B
| $6.42M | 1.43% | 435,995 -112,330 | -20% | -$1.65M |
|
|
MNTA
23
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $5.17M | 1.15% | 98,501 -25,837 | -21% | -$1.36M |
|
24
Viatris
VTRS
$12.3B
| $4.82M | 1.07% | +324,951 | New | +$4.82M |
|
|
ITCI
25
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.54M | 1.01% | +176,758 | New | +$4.54M |
|